Literature DB >> 26684523

Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.

Jeroen Kortekaas1, Rianka P M Vloet1, Alexander J McAuley2,3, Xiaoli Shen2,3, Berend Jan Bosch4, Laura de Vries4, Rob J M Moormann1,4, Dennis A Bente2,3.   

Abstract

Crimean-Congo hemorrhagic fever virus is a tick-borne bunyavirus of the Nairovirus genus that causes hemorrhagic fever in humans with high case fatality. Here, we report the development of subunit vaccines and their efficacy in signal transducer and activator of transcription 1 (STAT1) knockout mice. Ectodomains of the structural glycoproteins Gn and Gc were produced using a Drosophila insect cell-based expression system. A single vaccination of STAT129 mice with adjuvanted Gn or Gc ectodomains induced neutralizing antibody responses, which were boosted by a second vaccination. Despite these antibody responses, mice were not protected from a CCHFV challenge infection. These results suggest that neutralizing antibodies against CCHFV do not correlate with protection of STAT1 knockout mice.

Entities:  

Keywords:  Bunyavirus; Crimean–Congo hemorrhagic fever virus; Gc; Gn; Nairovirus; Neutralizing antibodies; STAT1; STAT129; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 26684523      PMCID: PMC7643766          DOI: 10.1089/vbz.2015.1855

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  16 in total

1.  Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.

Authors:  S M Ghiasi; A H Salmanian; S Chinikar; S Zakeri
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

2.  Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus.

Authors:  Kristin Spik; Amy Shurtleff; Anita K McElroy; Mary C Guttieri; Jay W Hooper; Connie SchmalJohn
Journal:  Vaccine       Date:  2005-08-22       Impact factor: 3.641

3.  Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.

Authors:  A Pekosz; C Griot; K Stillmock; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

4.  Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.

Authors:  Kyle S Brown; David Safronetz; Andrea Marzi; Hideki Ebihara; Heinz Feldmann
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

5.  Crimean-congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein.

Authors:  Angela J Sanchez; Martin J Vincent; Bobbie R Erickson; Stuart T Nichol
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  The role of interferons in rotavirus infections and protection.

Authors:  John L Vancott; Monica M McNeal; Anthony H C Choi; Richard L Ward
Journal:  J Interferon Cytokine Res       Date:  2003-03       Impact factor: 2.607

7.  Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.

Authors:  S M de Boer; J Kortekaas; A F Antonis; J Kant; J L van Oploo; P J M Rottier; R J M Moormann; B J Bosch
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

8.  Expression of interferon-induced antiviral genes is delayed in a STAT1 knockout mouse model of Crimean-Congo hemorrhagic fever.

Authors:  Gavin C Bowick; Adriana M Airo; Dennis A Bente
Journal:  Virol J       Date:  2012-06-19       Impact factor: 4.099

9.  BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge.

Authors:  Valentina Franceschi; Scott Parker; Sarah Jacca; Ryan W Crump; Konstantin Doronin; Edguardo Hembrador; Daniela Pompilio; Giulia Tebaldi; Ryan D Estep; Scott W Wong; Mark R Buller; Gaetano Donofrio
Journal:  PLoS Negl Trop Dis       Date:  2015-06-18

10.  A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.

Authors:  Karen R Buttigieg; Stuart D Dowall; Stephen Findlay-Wilson; Aleksandra Miloszewska; Emma Rayner; Roger Hewson; Miles W Carroll
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

View more
  33 in total

Review 1.  The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

Authors:  Marko Zivcec; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2020-01-22       Impact factor: 5.970

Review 2.  Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.

Authors:  Brian B Gowen; Brady T Hickerson
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

3.  Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.

Authors:  Michael E Lindquist; Xiankun Zeng; Louis A Altamura; Sharon P Daye; Korey L Delp; Candace Blancett; Kayla M Coffin; Jeffrey W Koehler; Susan Coyne; Charles J Shoemaker; Aura R Garrison; Joseph W Golden
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 4.  An Overview of Animal Models for Arthropod-Borne Viruses.

Authors:  Erin S Reynolds; Charles E Hart; Meghan E Hermance; Douglas L Brining; Saravanan Thangamani
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

5.  Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.

Authors:  David W Hawman; Kimberly Meade-White; Elaine Haddock; Rumi Habib; Dana Scott; Tina Thomas; Rebecca Rosenke; Heinz Feldmann
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

6.  Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.

Authors:  Marko Zivcec; Lisa I W Guerrero; César G Albariño; Éric Bergeron; Stuart T Nichol; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2017-08-24       Impact factor: 5.970

Review 7.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

8.  Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

Authors:  Jessica R Spengler; Stephen R Welch; Florine E M Scholte; JoAnn D Coleman-McCray; Jessica R Harmon; Stuart T Nichol; Éric Bergeron; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2019-08-01       Impact factor: 5.970

9.  Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.

Authors:  J Maximilian Fels; Daniel P Maurer; Andrew S Herbert; Ariel S Wirchnianski; Olivia Vergnolle; Robert W Cross; Dafna M Abelson; Crystal L Moyer; Akaash K Mishra; Jennifer T Aguilan; Ana I Kuehne; Noel T Pauli; Russell R Bakken; Elisabeth K Nyakatura; Jan Hellert; Gregory Quevedo; Leslie Lobel; Stephen Balinandi; Julius J Lutwama; Larry Zeitlin; Thomas W Geisbert; Felix A Rey; Simone Sidoli; Jason S McLellan; Jonathan R Lai; Zachary A Bornholdt; John M Dye; Laura M Walker; Kartik Chandran
Journal:  Cell       Date:  2021-06-01       Impact factor: 66.850

Review 10.  Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Marko Zivcec; Florine E M Scholte; Christina F Spiropoulou; Jessica R Spengler; Éric Bergeron
Journal:  Viruses       Date:  2016-04-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.